Increased Basal Ganglia Iron Levels in Huntington Disease

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282

Untitled work

(1976) · Medical Entomology and Zoology · Cited by 8,899

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380

The effect of age on the non-haemin iron in the human brain

Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,365

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

Beal, M. F., Brouillet, E., Jenkins, B. G., Ferrante, R. J., Kowall, N. W., Miller, J., Storey, E., Srivastava, R., Rosen, B. R., & Hyman, B. T. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,026

Psychological Statistics.

Katz, L., & McNemar, Q. (1963) · Journal of the American Statistical Association · doi:10.2307/2283304 · Cited by 991

The importance of free radicals and catalytic metal ions in human diseases.

Halliwell, B., & Gutteridge, J. M. C. (1985) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(85)90001-9 · Cited by 941

Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia

Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885

Intramuscular desferrioxamine in patients with Alzheimer's disease

MCLACHLAN, D. (1991) · The Lancet · doi:10.1016/0140-6736(91)92978-b · Cited by 764

New Perspectives on Oxidized Genome Damage and Repair Inhibition by Pro-Oxidant Metals in Neurological Diseases

Mitra, J., Guerrero, E. N., Hegde, P. M., Wang, H., Boldogh, I. R., Rao, K. S. J., MITRA, S. P., & Hegde, M. L. (2014) · Biomolecules · doi:10.3390/biom4030678 · Cited by 37

Iron and Parkinson's Disease: Chelators to the Rescue?

Levenson, C. W. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.sept.311-313 · Cited by 37

Mitochondrial and Redox-Based Therapeutic Strategies in Huntington's Disease

Fão, L., & Rego, A. C. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.8004 · Cited by 37

Mitochondrial metals as a potential therapeutic target in neurodegeneration

Grubman, A., White, A. R., & Liddell, J. R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12513 · Cited by 33

MR contrast of ferritin and hemosiderin in the brain: comparison among gradient-echo, conventional spin-echo and fast spin-echo sequences

Haque, T. L., Miki, Y., Kanagaki, M., Takahashi, T., Yamamoto, A., Konishi, J., Nozaki, K., Hashimoto, N., & Konishi, J. (2003) · European Journal of Radiology · doi:10.1016/s0720-048x(03)00054-8 · Cited by 33

A Review on Natural Antioxidants

Rasheed, A., & Azeez, R. F. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82636 · Cited by 30

Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington’s disease

Donley, D. W., Realing, M., Gigley, J. P., & Fox, J. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250606 · Cited by 31

Measurement of brain iron distribution in Hallevorden‐Spatz syndrome

Szumowski, J., Bas, E., Gaarder, K., Schwarz, E., Deniz Erdogmus, B., & Hayflick, S. J. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22031 · Cited by 29

Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington's Disease: Preclinical Evidence with the p75NTR Ligand LM11A-31

Simmons, D. A., Mills, B. D., Butler, R. R., Kuan, J., McHugh, T. L. M., Akers, C. S., Zhou, J., Syriani, W., Goubran, M., Zeineh, M., et al. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01023-8 · Cited by 28

Correlation between Relaxometry and Diffusion Tensor Imaging in the Globus Pallidus of Huntington’s Disease Patients

Syka, M., Keller, J., Klempíř, J., Rulseh, A. M., Roth, J., Jech, R., Voříšek, I., & Vymazal, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118907 · Cited by 28

Mutations in the hemochromatosis gene (HFE) and multiple sclerosis

Ristič, S., Lovrečić, L., Brajenović‐Milić, B., Čizmarević, N. S., Jazbec, S. Š., Sepčić, J., Kapović, M., & Peterlin, B. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.04.045 · Cited by 26

Structural Magnetic Resonance Imaging in Huntington's Disease

Wilson, H., Dervenoulas, G., & Politis, M. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.09.006 · Cited by 25

Altered Intracortical T1-Weighted/T2-Weighted Ratio Signal in Huntington’s Disease

Rowley, C. D., Tabrizi, S. J., Scahill, R. I., Leavitt, B. R., Roos, R. A. C., Dürr, A., & Bock, N. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00805 · Cited by 25

The Role of Iron in Parkinson Disease and 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Toxicity

Yantiri, F., & Andersen, J. K. (1999) · IUBMB Life · doi:10.1080/713803493 · Cited by 25

Age-related structural changes in the human midbrain: an MR image study

Sohmiya, M., Tanaka, M., Aihara, Y., Hirai, S., & Okamoto, K. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00227-5 · Cited by 25

Iron uptake at the blood-brain barrier is influenced by sex and genotype

Wade, Q. W., Chiou, B., & Connor, J. R. (2019) · Advances in pharmacology · doi:10.1016/bs.apha.2019.02.005 · Cited by 24

Iron is a specific cofactor for distinct oxidation- and aggregation-dependent Aβ toxicity mechanisms

Ott, S., Dziadulewicz, N., & Crowther, D. C. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.019042 · Cited by 23

Tert-butylhydroquinone protects PC12 cells against ferrous sulfate-induced oxidative and inflammatory injury via the Nrf2/ARE pathway

Xu, W., Li, F., Xu, Z., Sun, B., Cao, J., & Liu, Y. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.05.021 · Cited by 23

T1ρ imaging in premanifest Huntington disease reveals changes associated with disease progression

Wassef, S. N., Wemmie, J. A., Johnson, C. P., Johnson, H. J., Paulsen, J. S., Long, J. D., & Magnotta, V. A. (2015) · Movement Disorders · doi:10.1002/mds.26203 · Cited by 21

The Role of Iron Imaging in Huntington’s Disease

van den Bogaard, S. J. A., Dumas, E. M., & Roos, R. A. C. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-410502-7.00011-9 · Cited by 18

Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases

Wang, L., Fang, X., Ling, B., Wang, F., Xia, Y., Zhang, W., Zhong, T., & Wang, X. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1359453 · Cited by 18

Multi-compartment analysis of the complex gradient-echo signal quantifies myelin breakdown in premanifest Huntington's disease

Casella, C., Kleban, E., Rosser, A., Coulthard, E. J., Rickards, H. E., Fasano, F., Metzler‐Baddeley, C., & Jones, D. K. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102658 · Cited by 15

Quantitative 7T Phase Imaging in Premanifest Huntington Disease

Apple, A. C., Possin, K. L., Satris, G., Johnson, E. T., Lupo, J., Jakary, A., Wong, K., Kelley, D. A. C., Kang, G. A., Sha, S. J., et al. (2014) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3932 · Cited by 15

Comparison of quantitative susceptibility mapping methods for iron-sensitive susceptibility imaging at 7T: An evaluation in healthy subjects and patients with Huntington's disease

Yao, J., Morrison, M. A., Jakary, A., Avadiappan, S., Chen, Y., Luitjens, J., Glueck, J. A., Driscoll, T., Geschwind, M. D., Nelson, A., et al. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119788 · Cited by 14

Iron regulation in C57BL/6 and DBA/2 mice subjected to iron overload

Unger, E. L., Beard, J. L., & Jones, B. C. (2007) · Nutritional Neuroscience · doi:10.1080/10284150701350653 · Cited by 14

An Updated Overview of the Magnetic Resonance Imaging of Brain Iron in Movement Disorders

Tambasco, N., Nigro, P., Chiappiniello, A., Paoletti, F. P., Scialpi, S., Simoni, S., Chiarini, P., & Parnetti, L. (2022) · Behavioural Neurology · doi:10.1155/2022/3972173 · Cited by 14

Demonstration of striatopallidal iron deposition in chorea-acanthocytosis by susceptibility-weighted imaging

Lee, J., Lee, S.-M., & Baik, S. K. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5725-y · Cited by 14

3D high spectral and spatial resolution imaging of ex vivo mouse brain

Foxley, S., Domowicz, M. S., Karczmar, G. S., & Schwartz, N. B. (2015) · Medical Physics · doi:10.1118/1.4908203 · Cited by 13

Mutation‐related magnetization‐transfer, not axon density, drives white matter differences in premanifest Huntington disease: Evidence from in vivo ultra‐strong gradient MRI

Casella, C., Chamberland, M., Laguna, P. A. L., Parker, G. D., Rosser, A., Coulthard, E. J., Rickards, H. E., Berry, S. C., Jones, D. K., & Metzler‐Baddeley, C. (2022) · Human Brain Mapping · doi:10.1002/hbm.25859 · Cited by 11

Genotype and allele frequencies of divalent metal transporter 1 polymorphism in Turkish population

Kayaaltı, Z., Odabaşi, M., & Söylemezoğlu, T. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0410-x · Cited by 13

Movement Disorder Genetics

Brás, J., & Schneider, S. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-17223-1 · Cited by 12

Oxidative Stress in Huntington’s Disease

Jiménez‐Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., Cárcamo-Fonfría, A., Caballero-Muñoz, M. D. M., & Agúndez, J. A. G. (2025) · Biomolecules · doi:10.3390/biom15040527 · Cited by 13

Quantitative assessment of brain iron by R 2* relaxometry in patients with cervical dystonia

Aschermann, Z., Perlaki, G., Orsi, G., Nagy, S. A., Horváth, A., Bóné, B., Bihari, K., Ács, P., Janszky, J., Komoly, S., et al. (2015) · Movement Disorders · doi:10.1002/mds.26306 · Cited by 11

Reviewing Biochemical Implications of Normal and Mutated Huntingtin in Huntington’s Disease

Tellone, E., Galtieri, A., & Ficarra, S. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190621101909 · Cited by 9

Enfermedad de Huntington: una visión biomolecular

Leite, J. F. (2001) · Revista de Neurología · doi:10.33588/rn.3208.2000484 · Cited by 8

A series of cases with Huntington-like phenotype and intermediate repeats in HTT

Acuña, A. R., Martín, E. S. S., Fernández, C. G., Menéndez, S. F., Estrada, M. B., Amorin-Díaz, M., Menéndez‐González, M., & Martínez, V. Á. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117452 · Cited by 8

Targeting Aging and Diseases Associated with Ferroptosis and Senescence Through Modulation of Iron, Oxidative Stress and Lipid Peroxidation

Kourti, M., & Kontoghiorghes, G. J. (2025) · Antioxidants · doi:10.3390/antiox15010015 · Cited by 11

Neuroinflammation in Alzheimer's, Parkinson's and Huntington's Diseases

Sastre, M., Katsouri, L., Birch, A. M., Renziehausen, A., Dexter, D. T., Crichton, R. R., & Ward, R. J. (2014) · Wiley eBooks · doi:10.1002/9781118406557.ch6 · Cited by 6

Nuclear translocation of STAT5 initiates iron overload in huntington’s disease by up-regulating IRP1 expression

Niu, L., Zhou, Y., Wang, J., & Zeng, W. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01340-9 · Cited by 5

Targeting dysregulation of brain iron homeostasis in ageing

Weinreb, O., Amit, T., & Youdim, M. B. H. (2012) · Nutrition and Aging · doi:10.3233/nua-2012-0003 · Cited by 5

MRI of Brain Iron and Neurodegenerative Diseases: A Potential Biomarker

Schenck, J. F. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-462-9_13 · Cited by 5

Huntington Disease

Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50018-8 · Cited by 5

Contribution of Disturbed Iron Metabolism to the Pathogenesis of Parkinson‘s Disease

Berg, D., Riederer, P. F., & Gerlach, M. (2008) · Future Neurology · doi:10.2217/14796708.3.4.447 · Cited by 4

Magnetic resonance imaging in Huntington's disease

Belogianni, C., Wilson, H., de Natale, E. R., & Politis, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821651-4.00001-4 · Cited by 4

Expression of RNAs Coding for Metal Transporters in Blood of Patients with Huntington’s Disease

Szeliga, M., Różycka, A., Jędrak, P., Barańska, S., Janik, P., Jamrozik, Z., & Albrecht, J. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1737-4 · Cited by 3

Metal Transporters in Neurodegeneration

Jiang, H. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00016-6 · Cited by 3

Genetics of NBIA Disorders

Wiethoff, S., Bhatia, K. P., & Houlden, H. (2015) · Springer eBooks · doi:10.1007/978-3-319-17223-1_13 · Cited by 3

Off‐resonance saturation as an MRI method to quantify mineral‐ iron in the post‐mortem brain

Bossoni, L., Hegeman-Kleinn, I. M., van Duinen, S. G., Bulk, M., Vroegindeweij, L. H. P., Langendonk, J. G., Hirschler, L., WEBB, A. G., & van der Weerd, L. (2021) · Magnetic Resonance in Medicine · doi:10.1002/mrm.29041 · Cited by 2

Patterns of abnormal magnetic susceptibility in the brain: an image-based review

Weger, K. L., Carr, C. M., Silvera, V. M., Oien, M., Edmonson, H. A., Do, B., & Little, J. T. (2025) · Neuroradiology · doi:10.1007/s00234-025-03588-z · Cited by 2

Imaging Biomarkers in Huntington’s Disease

de Natale, E. R., Wilson, H., & Politis, M. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_19 · Cited by 2

Does hereditary hemochromatosis influence the age of onset of Huntington's disease?

Walker, F. O. (2010) · Movement Disorders · doi:10.1002/mds.22695 · Cited by 2

Manganese and Huntington Disease

Tidball, A. M., Bichell, T. J., & Bowman, A. B. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622383-00540 · Cited by 2

Drug Design of Mitochondria-Targeted Antioxidants, Action, Metabolism and Perspectives for Ophthalmic Therapeutics: N-acetylcarnosine Codrug Treatment Platform

Babizhayev, M. A. (2017) · International Journal of Ophthalmology & Eye Science · doi:10.19070/2332-290x-1700062 · Cited by 2

Iron and Brain Function

Connor, J. R., & Piñero, D. J. (2005) · Nutrition, brain, and behavior./Nutrition, brain and behavior · doi:10.1201/9780203564554.ch14 · Cited by 2

CAG Repeat Instability in the Peripheral and Central Nervous System of Transgenic Huntington’s Disease Monkeys

Cho, I. K., Clever, F., Hong, G., & Chan, A. W. S. (2022) · Biomedicines · doi:10.3390/biomedicines10081863 · Cited by 2

Metal Biology Associated with Huntington’s Disease

Bichell, T. J., Halbesma, T. C., Tipps, K. G., & Bowman, A. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00013-0 · Cited by 2

Potent antioxidant and mitochondrial-protective effects of ATH434, a moderate affinity iron chaperone

Bailey, D. K., Nihlawi, R., BRADBURY, M. J., Bond, S., & Kosman, D. J. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110595 · Cited by 1

In vitro study of iron deposition in normal human brains: An Indian Scenario

Jaggi, S., Khandelwal, N. K., Sahni, D., & Vasishta, R. K. (2017) · Clinical Anatomy · doi:10.1002/ca.22989 · Cited by 1

Incidental evidence of hypointensity in brain grey nuclei on routine MR imaging: when to suspect a neurodegenerative disorder?

Morelli, M., Quattrone, A., Arabia, G., Vescio, B., Vaccaro, M. G., Mechelli, A., Rocca, F., Gambardella, A., & Quattrone, A. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05292-1 · Cited by 1

Neuroimaging Biomarkers for Huntington’s Disease

van de Zande, N. A., Ghariq, E., de Bresser, J., & de Bot, S. T. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102528 · Cited by 1

How molecular imaging studies can disentangle disease mechanisms in age-related neurodegenerative disorders

de Natale, E. R., Wilson, H., Udeh‐Momoh, C. T., Ford, J. K., Politis, M., & Middleton, L. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823761-8.00022-7 · Cited by 1

Huntington Disease and Other Genetic Choreas

Ha, A. D., & Jankovic, J. J. (2011) · Wiley eBooks · doi:10.1002/9781444346183.ch10 · Cited by 1

A Neurodevelopmental Origin for Pakinson's Disease: A Link to the Fetal Basis for Adult Disease Hypothesis

Urbach‐Ross, D., & Thiruchelvam, M. J. (2010) · doi:10.1002/9780470917060.ch13 · Cited by 1

Huntington's Disease and Polyglutamine Expansion Neurodegenerative Diseases

Crichton, R. R., & Ward, R. J. (2005) · doi:10.1002/0470022574.ch5 · Cited by 1

Novel Synchrotron-Based Analyses of Metal Pathology in Friedreich’s Ataxia

Popescu, B. F. G. (2009) · University Library - University of Saskatchewan (University of Saskatchewan)

Zebrafish Models of Heme Synthesis and Iron Metabolism

Fraenkel, P. G. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_31

Quantitative 7T Phase Imaging in Premanifest

Satris, G., Johnson, E. T., Jakary, A., & Wong, K. P. C. (2014)

G06 Iron defect is implicated in white matter changes in Huntington disease

Paola, M. D., Phillips, O., Sánchez‐Castañeda, C., Pardo, A. D., Maglione, V., Caltagirone, C., Sabatini, U., & Squitieri, F. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303524.86

G08 A multicentre approach for the detection of patterns of impairment in Huntington's disease by using diffusion tensor imaging

Mueller, H.-P., Sprengelmeyer, R., Süssmuth, S., Groen, G., Hobbs, N. Z., Roos, R. A. C., Dürr, A., Schoonderbeek, A., Hart, E., Valabrègue, R., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303524.88

G05 Alterations in iron content in the brain of Huntington disease mutation carriers in comparison with healthy control subjects

Sánchez‐Castañeda, C., Paola, M. D., Elifani, F., Maglione, V., Pardo, A. D., Sabatini, U., & Squitieri, F. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303524.85

Iron imaging in neurodegenerative disorders

Vemuri, P., & Jack, C. R. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9781139193481.044

A REVIEW ON- ANTIOXIDANTS

Tejasri, M., Kumar, D., Ramya, M., Revathi, K., Avinash, G., & Reddy, K. H. (2012)

Off-resonance saturation as an MRI method to quantify ferritin-bound iron in the post-mortem brainPreprint

Bossoni, L., Hegeman-Kleinn, I. M., van Duinen, S. G., Vroegindeweij, L. H. P., Langendonk, J. G., Hirschler, L., WEBB, A. G., & van der Weerd, L. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.22.436424

White matter changes in Huntington’s disease and the demyelination hypothesis: a critical reviewPreprint

Casella, C., Metzler‐Baddeley, C., Jones, D. K., & Lipp, I. (2019) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/u8p9b

Mutation-related apparent myelin, not axon density, drives white matter differences in premanifest Huntington’s disease: Evidence from in vivo ultra-strong gradient MRIPreprint

Casella, C., Chamberland, M., Laguna, P. A. L., Parker, G. D., Rosser, A., Coulthard, E. J., Rickards, H. E., Berry, S. C., Jones, D. K., & Metzler‐Baddeley, C. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.29.469517

H

Lachman, R. S. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-01931-6.50016-5

Huntington's Disease and Polyglutamine Expansion Neurodegenerative Diseases

(2013) · doi:10.1002/9781118553480.ch08

Proteomics in Huntington’s Disease Biomarker Discovery

Červenka, J., Budkova, K., Suchá, R., Vodička, P., & Voukali, E. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-32815-2_9

I deficit cognitivi nelle sindromi extrapiramidali con demenza

Perri, R., & Carlesimo, G. A. (2009) · Springer eBooks · doi:10.1007/978-88-470-1490-9_4

Développement et validation d'une méthode de relaxométrie T2* bi-exponentielle en IRM cérébrale

Michaud, M. (2020) · doi:10.70675/fb5210d4zbf51z4333zbbfczab9303a0019b

Metal Ions and Protein Aggregation: Unraveling Molecular Interactions and Theranostic Prospects in Proteinopathies

Milardi, D., Han, J., Lee, H. J., Ding, F., Miller, Y., Faller, P., Bush, A. I., Crouch, P. J., Finkelstein, D. I., Double, K. L., et al. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00420

SurR9-C84A mutant nanocarrier and milk protein therapeutics for neurological disorders

Sriramoju, B. (2014) · Own your potential (DEAKIN)

Iron accumulation in the basal ganglia in Huntington's disease: Cross-sectional data from the IMAGE-HD study

(14451801), J. D. D., (15808028), A. N., (13437798), G. P., Stout, J. C., (10042406), A. C., (13518502), P. C., (14453715), G. E., & (13324965), N. G.-K. (2024) · Figshare

MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.

Bartzokis, G., & Tishler, T. A. (2000) · PubMed · Cited by 196

The role of iron in gray matter degeneration in Huntington's disease: A magnetic resonance imaging study

Sánchez‐Castañeda, C., Squitieri, F., Paola, M. D., Dayan, M., Petrollini, M., & Sabatini, U. (2014) · Human Brain Mapping · doi:10.1002/hbm.22612 · Cited by 46

E07 Progressive Iron Accumulation In Huntington Disease Basal Ganglia: A Longitudinal Study

Sánchez‐Castañeda, C., Hagberg, G. E., Squitieri, F., & Sabatini, U. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309032.110

E08 Iron Content in Brain Increases with Progression of Huntington's Disease: Longitudinal Study

Klempíř, J., Keller, J., Vymazal, J., Syka, M., Štochl, J., Jech, R., Židovská, J., & Roth, J. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309032.111